TGFBR1 and dysplasia: To fully assess the expression of TβRI, II, and III in clinical samples and determine their role in OSCC carcinogenesis and prognosis, 138 specimens were examined that represented four clinicopathological stages (including normal epithelium tissues, OLK without dysplasia, OLK with dysplasia, and infiltrated OSCCs).